Browse studies

Find your next paid study

26,786 recruiting studies available now

Molecular Fingerprinting of Lung Cancer

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and ide…

Lung Cancer

Estimated

~$10 – $750

Vanderbilt-Ingram Cancer CenterNCT00897117

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore the…

StrokeStroke, AcuteStroke, Ischemic

Estimated

~$10 – $750

Yale UniversityNCT05338697

Phase 2

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab for Patients With Resectable Stage IB - III Non-Small Cell Lung Cancer

This single-arm phase 2 study will enroll patients with resectable and operable stage IB - III non-small cell lung cancer and treat them with pre-operative ipi…

Non Small Cell Lung Cancer

Estimated

~$10 – $6,250

Brown UniversityNCT04933903

Phase 4

A Phase 4, Single-Arm, Multicenter Study of Prophylactic Tocilizumab in Participants With Relapsed/Refractory Multiple Myeloma Treated With Linvoseltamab in the Outpatient Setting

This study is researching whether the use of tocilizumab before the first dose of linvoseltamab will decrease the risk of Cytokine Release Syndrome (CRS) in pa…

Relapsed/Refractory Multiple Myeloma (RRMM)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07609940

Phase 2

A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, and Efficacy of MZE782 in Adults With Phenylketonuria (PKU)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).

Phenylketonuria (PKU)

Estimated

~$10 – $8,750

Maze TherapeuticsNCT07694440

Observational

Development of a Power Training Program to Improve Mobility in Older Veterans

The overall purpose of this study is to develop a power training intervention in partnership with Veterans participating in Gerofit and to evaluate the program…

Physical DeconditioningMobility Decline

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT07210645

Phase 2

Randomised, Placebo-controlled, Double-blind, Parallel-group Phase II Study to Evaluate the Efficacy and Safety of Oral BI 3000202 in Patients With Moderate to Severe Systemic Lupus Erythematosus (SLE)

This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps peopl…

Systemic Lupus Erythematosus

Estimated

~$10 – $7,500

Boehringer IngelheimNCT07409181

Phase 2

Substance Use in Pregnancy- Optimizing Retention in Treatment by Maximizing Opportunities for Management

Overdose is a national top-three leading cause of pregnancy-associated death, and maternal substance use disorder (SUD) accounts for an estimated $1.5 billion …

PregnancySubstance Use Disorder (SUD)

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07776457

Phase 1

A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of Two Eloralintide Solutions in Healthy Participants

The main purpose of this study is to learn about safety, tolerability and how well the body processes two different eloralintide solutions. Participation in th…

Healthy Volunteers

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07701083

Phase 4

3-Dimensional Volumetric Analysis of a Hyaluronic Filler Injection for Chin Profile Enhancement

The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The primary aim of…

Chin RegressionChin AsymmetryJawline Contour Deficit

Estimated

~$10 – $6,250

University of PennsylvaniaNCT07777926

An Observational Multi-Country Post-Authorisation Safety Study to Evaluate the Risk of Serious Adverse Cardiovascular Events in Adolescent and Adult Patients With Severe Asthma Taking Tezepelumab

The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab c…

Cardiovascular EventsMACE

Estimated

~$10 – $1,125

AstraZenecaNCT06951867

Observational

Acute Changes in Optic Nerve Head (ONH) and Macular Blood Flow After Caffeine Consumption in Glaucoma Patients and Healthy Subjects: A Quantitative Optic Coherence Tomography Angiography (OCTA) Study

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow du…

Glaucoma, Primary Open Angle

Estimated

~$10 – $7,500

Wills EyeNCT03675412